We conclude that TNFSF14-derived molecules positively regulate glucose homeostasis and lipid metabolism and may therefore open a completely novel therapeutic pathway for treating obesity and T2D. Here, TNFSF14 is linked to obesity due to melanocortin 4 receptor deficiency.